MOLECULAR MECHANISMS OF MORINGA OLEIFERA: REGULATION OF COX-2 AND APOPTOTIC SIGNALING

Moringa oleifera Lam. is a medicinal plant widely recognized for its exceptional nutritional value and diverse pharmacological activities, largely attributed to its rich repertoire of bioactive phytochemicals, including flavonoids, isothiocyanates, phenolic acids, glucosinolates, and alkaloids. Increasing evidence suggests that these phytoconstituents exert significant anti-inflammatory and anticancer effects by modulating multiple molecular signaling pathways. This review comprehensively summarizes the molecular mechanisms through which Moringa oleifera regulates cyclooxygenase-2 (COX-2) and apoptosis-associated signaling pathways. Particular emphasis is placed on the suppression of COX-2 expression and activity through inhibition of nuclear factor-kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and related inflammatory mediators, leading to reduced production of prostaglandins and pro-inflammatory cytokines. The review further discusses the role of Moringa oleifera phytochemicals in inducing apoptosis via both intrinsic and extrinsic pathways through modulation of Bax/Bcl-2 balance, cytochrome c release, caspase activation, reactive oxygen species (ROS)-mediated mitochondrial dysfunction, and cell cycle arrest. Experimental findings from in vitro and in vivo studies demonstrate the plant's ability to inhibit inflammation, suppress tumor growth, and selectively induce apoptosis in malignant cells while exhibiting minimal toxicity toward normal tissues. Despite promising preclinical evidence, challenges related to phytochemical standardization, bioavailability, pharmacokinetics, and clinical validation remain significant barriers to therapeutic translation. Future research integrating molecular pharmacology, nanotechnology-based delivery systems, and well-designed clinical studies is essential to establish the clinical efficacy and safety of Moringa oleifera-derived phytopharmaceuticals. Overall, Moringa oleifera represents a promising multitarget natural therapeutic agent for the prevention and management of inflammation-associated diseases and cancer.

Authors

Publication Details

Journal
World Journal of Pharmaceutical Research
Published
2026-09-16
DOI
https://doi.org/10.5281/zenodo.22808684
Primary Topic
Moringa oleifera research and applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

MOLECULAR MECHANISMS OF MORINGA OLEIFERA: REGULATION OF COX-2 AND APOPTOTIC SIGNALING

Ruchi Maurya*, Mr. Ran Vijay Singh, Dr. Sanjay Kumar Kuswaha1
World Journal of Pharmaceutical Research
Moringa oleifera research and applications
article

MOLECULAR MECHANISMS OF MORINGA OLEIFERA: REGULATION OF COX-2 AND APOPTOTIC SIGNALING

Ruchi Maurya*, Mr. Ran Vijay Singh, Dr. Sanjay Kumar Kuswaha1
article en

Abstract

Moringa oleifera Lam. is a medicinal plant widely recognized for its exceptional nutritional value and diverse pharmacological activities, largely attributed to its rich repertoire of bioactive phytochemicals, including flavonoids, isothiocyanates, phenolic acids, glucosinolates, and alkaloids. Increasing evidence suggests that these phytoconstituents exert significant anti-inflammatory and anticancer effects by modulating multiple molecular signaling pathways. This review comprehensively summarizes the molecular mechanisms through which Moringa oleifera regulates cyclooxygenase-2 (COX-2) and apoptosis-associated signaling pathways. Particular emphasis is placed on the suppression of COX-2 expression and activity through inhibition of nuclear factor-kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and related inflammatory mediators, leading to reduced production of prostaglandins and pro-inflammatory cytokines. The review further discusses the role of Moringa oleifera phytochemicals in inducing apoptosis via both intrinsic and extrinsic pathways through modulation of Bax/Bcl-2 balance, cytochrome c release, caspase activation, reactive oxygen species (ROS)-mediated mitochondrial dysfunction, and cell cycle arrest. Experimental findings from in vitro and in vivo studies demonstrate the plant's ability to inhibit inflammation, suppress tumor growth, and selectively induce apoptosis in malignant cells while exhibiting minimal toxicity toward normal tissues. Despite promising preclinical evidence, challenges related to phytochemical standardization, bioavailability, pharmacokinetics, and clinical validation remain significant barriers to therapeutic translation. Future research integrating molecular pharmacology, nanotechnology-based delivery systems, and well-designed clinical studies is essential to establish the clinical efficacy and safety of Moringa oleifera-derived phytopharmaceuticals. Overall, Moringa oleifera represents a promising multitarget natural therapeutic agent for the prevention and management of inflammation-associated diseases and cancer.

World Journal of Pharmaceutical Research
Openalex Percentile: Top 12%
Moringa oleifera research and applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.